TUL FY2025 profit attributable to owners falls 21.6% to RMB 2.09 billion

Reuters03-24 23:01

TUL FY2025 profit attributable to owners falls 21.6% to RMB 2.09 billion

United Laboratories published its 2025 annual results announcement, reporting revenue of RMB13.21 billion, down 4.0%.
EBITDA was RMB3.25 billion, down 17.6%, while profit before taxation fell 23.1% to RMB2.53 billion.
Net income attributable to owners was RMB2.09 billion, down 21.6%, and basic earnings per share were RMB110.65 cents, down 24.4%.
A final dividend of RMB26 cents per share was recommended, taking the full-year dividend to RMB42 cents per share, down 25.0%.
Finished products external sales were RMB6.70 billion, up 41.7%, including RMB1.44 billion of license fee income recognized from an exclusive UBT251 out-licensing agreement; intermediate products and bulk medicine external sales fell 39.4% to RMB1.61 billion and 23.1% to RMB4.90 billion, with management citing lower market prices for those products.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TUL - The United Laboratories International Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260324-12065759), on March 24, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2621096807?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-24 23:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2621096807","market":"fut","top_or_hot":-1,"title":"TUL FY2025 profit attributable to owners falls 21.6% to RMB 2.09 billion","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      TUL FY2025 profit attributable to owners falls 21.6% to RMB 2.09 billion\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<ul>\n<li>\n          United Laboratories published its 2025 annual results announcement, reporting revenue of RMB13.21 billion, down 4.0%.\n        </li>\n<li>\n          EBITDA was RMB3.25 billion, down 17.6%, while profit before taxation fell 23.1% to RMB2.53 billion.\n        </li>\n<li>\n          Net income attributable to owners was RMB2.09 billion, down 21.6%, and basic earnings per share were RMB110.65 cents, down 24.4%.\n        </li>\n<li>\n          A final dividend of RMB26 cents per share was recommended, taking the full-year dividend to RMB42 cents per share, down 25.0%.\n        </li>\n<li>\n          Finished products external sales were RMB6.70 billion, up 41.7%, including RMB1.44 billion of license fee income recognized from an exclusive UBT251 out-licensing agreement; intermediate products and bulk medicine external sales fell 39.4% to RMB1.61 billion and 23.1% to RMB4.90 billion, with management citing lower market prices for those products.\n        </li>\n</ul>\n<br/>\n<br/>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TUL - The <a href=\"https://laohu8.com/S/ULIHF\">United Laboratories International Holdings Ltd.</a> published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260324-12065759), on March 24, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TUL FY2025 profit attributable to owners falls 21.6% to RMB 2.09 billion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTUL FY2025 profit attributable to owners falls 21.6% to RMB 2.09 billion\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-24 23:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      TUL FY2025 profit attributable to owners falls 21.6% to RMB 2.09 billion\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<ul>\n<li>\n          United Laboratories published its 2025 annual results announcement, reporting revenue of RMB13.21 billion, down 4.0%.\n        </li>\n<li>\n          EBITDA was RMB3.25 billion, down 17.6%, while profit before taxation fell 23.1% to RMB2.53 billion.\n        </li>\n<li>\n          Net income attributable to owners was RMB2.09 billion, down 21.6%, and basic earnings per share were RMB110.65 cents, down 24.4%.\n        </li>\n<li>\n          A final dividend of RMB26 cents per share was recommended, taking the full-year dividend to RMB42 cents per share, down 25.0%.\n        </li>\n<li>\n          Finished products external sales were RMB6.70 billion, up 41.7%, including RMB1.44 billion of license fee income recognized from an exclusive UBT251 out-licensing agreement; intermediate products and bulk medicine external sales fell 39.4% to RMB1.61 billion and 23.1% to RMB4.90 billion, with management citing lower market prices for those products.\n        </li>\n</ul>\n<br/>\n<br/>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TUL - The <a href=\"https://laohu8.com/S/ULIHF\">United Laboratories International Holdings Ltd.</a> published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260324-12065759), on March 24, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"制药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDL7wmxM:1","article_id":"2621096807","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2621096807","pubTimestamp":1774364496,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"United Laboratories published its 2025 annual results announcement, reporting revenue of RMB13.21 billion, down 4.0%.EBITDA was RMB3.25 billion, down 17.6%, while profit before taxation fell 23.1% to RMB2.53 billion.Net income attributable to owners was RMB2.09 billion, down 21.6%, and basic earnings per share were RMB110.65 cents, down 24.4%.Finished products external sales were RMB6.70 billion, up 41.7%, including RMB1.44 billion of license fee income recognized from an exclusive UBT251 out-licensing agreement; intermediate products and bulk medicine external sales fell 39.4% to RMB1.61 billion and 23.1% to RMB4.90 billion, with management citing lower market prices for those products.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. T","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1191":"制药","03933":"联邦制药"},"translate_title":"TUL 2025财年所有者应占利润下降21.6%至人民币20.9亿元","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03933":0.9},"content_text":"TUL FY2025 profit attributable to owners falls 21.6% to RMB 2.09 billion\n    \n\n\n          United Laboratories published its 2025 annual results announcement, reporting revenue of RMB13.21 billion, down 4.0%.\n        \n\n          EBITDA was RMB3.25 billion, down 17.6%, while profit before taxation fell 23.1% to RMB2.53 billion.\n        \n\n          Net income attributable to owners was RMB2.09 billion, down 21.6%, and basic earnings per share were RMB110.65 cents, down 24.4%.\n        \n\n          A final dividend of RMB26 cents per share was recommended, taking the full-year dividend to RMB42 cents per share, down 25.0%.\n        \n\n          Finished products external sales were RMB6.70 billion, up 41.7%, including RMB1.44 billion of license fee income recognized from an exclusive UBT251 out-licensing agreement; intermediate products and bulk medicine external sales fell 39.4% to RMB1.61 billion and 23.1% to RMB4.90 billion, with management citing lower market prices for those products.\n        \n\n\n\n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TUL - The United Laboratories International Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260324-12065759), on March 24, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2621096807","isCrawlerRequest":true}